Carvedilol — Drug Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

7 Registered trials

6 Recruiting

1 Completed trials

7 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 5

Indications tested

7 total

Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Phase IV 1 country Policlinico San Donato S.p.A.
Effect of long-term carvedilol to prevent decompensation or death in patients with asymptomatic Child-Pugh A5 to B8 cirrhosis and clinically… Recruiting

2024-511663-28-00 Phase IV 1 country Centre Hospitalier Regional Universitaire De Tours
Effect of Carvedilol on the portosystemic gradient as measured by endoscopic ultrasound Recruiting

2024-518302-41-00 Phase II 1 country University Hospital Of Clermont-Ferrand
Carvedilol vs. flecainida clinical trial in idiopathic ventricular arrhythmias. Recruiting

2023-510362-26-00 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
Use of determination of drug levels to optimize pharmacotherapy of heart failure Recruiting

2023-506283-13-00 Phase IV 1 country Fakultni Nemocnice Ostrava
CROWD-COMPARE Recruiting

2022-503010-23-01 Phase IV 1 country Odense University Hospital
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Phase III 1 country Frederiksberg Hospital

Showing 1–7 of 7 trials